LMAT

Lemaitre Vascular Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth 7/10
  • Value 1/10
Lemaitre Vascular sales and earnings growth
LMAT Growth
Good
  • Revenue Y/Y 13.27%
  • EPS Y/Y 36.63%
  • FCF Y/Y 92.43%
Lemaitre Vascular gross and profit margin trends
LMAT Profitability
Great
  • Gross margin 72.40%
  • EPS margin 24.30%
  • ROIC 5Y 17.72%
Lemaitre Vascular recent dividend growth
LMAT Dividends
  • Dividend yield 0.98%
  • Growth 3Y 21.06%
  • Payout ratio 31%
Lemaitre Vascular net debt vs free cash flow
LMAT Risk
Great
  • Debt / Equity 0.5
  • Debt / FCF 2.1
  • Interest coverage 16.5

Lemaitre Vascular stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Medical Instruments & Supplies stocks